查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1146144

早产和 PROM 测试市场 - 增长、趋势、COVID-19 影响和预测 (2022-2027)

Preterm Birth and PROM Testing Market - Growth, Trends, And Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内 (2022-2027)，早产和 PROM 检测市场预计将以 3.35% 的复合年增长率增长。

COVID-19 大流行对早产和 PROM 检测市场产生了重大影响。根据 2020 年 10 月发表在国际妇产科杂誌上的题为“COVID-19 大流行对孕产妇健康的影响”的研究，“COVID-19 大流行导致人们寻求医疗护理。延迟对孕产妇健康的影响”。来自三级中心的经验”，三分之一的妇女没有进行足够的产前检查。坐月子和害怕感染是延误就医的主要原因，44.7% 的妊娠以併发症告终。此外，2020 年 7 月发表在《妇产科调查》上的一份报告发现，怀孕期□□间感染 COVID-19 会增加早产、胎膜早破等妊娠并发症的风险，在极少数情况下还会导致孕产妇死亡。 因此，早产和 PROM 检测正在兴起，用于产前检测和预防并减少併发症。因此，由于对护理的需求不断增加，市场预计会上涨。

市场增长的驱动因素包括全球范围内早产和低出生体重的增加、床旁诊断的进步和 PROM 测试工具的技术进步，以及对早产和 PROM 测试可用性的认识的提高。

早产率和早产儿死亡率上升是预测期内市场增长的主要驱动力。美国疾病控制与预防中心公布的数据显示，2021年，14.9%的非裔美国女性会早产，比白人（9.1%）和西班牙裔女性（9.8%）高出50个百分点。同样，March of Dimes 发布的统计数据证实，到 2021 年，黑人女性的早产率将从 14.25% 上升到 14.36%，美洲印第安人/阿拉斯加原住民母亲的早产率将从 11.55% 上升到 11.61%。此外，在美国疾病控制与预防中心2021年发表的一篇题为《早产》的论文中，据报导，2020年，美国出生的婴儿中有十分之一会早产。

此外，越来越多的人前往诊断实验室和医疗机构进行检测，尤其是在新兴地区，这也有助于预测期内的市场扩张。诊断中心正变得越来越流行和广泛使用，因为它们具有更高的可靠性、成本效益、更快的结果以及以更低的成本提供准确的诊断结果。

然而，不可用的 PROM 检查服务和欠发达国家的经济限制可能会阻碍市场增长。

主要市场趋势

预计超音波业务在预测期内将保持较高的复合年增长率

由于早产发生率的增加、公司研发活动的增加以及检测和预测早产的技术进步等因素，预计超声诊断领域在预测期内将出现显着增长。

因为超音波扫描会产生子宫和婴儿的图像，它们可以用来检查宫颈组织，看看宫颈是否扩张或脱出，也可以用来提高诊断和预测早产。我可以做吧。

随着早产发生率和相关后果的增加，孕妇更有可能在怀孕期间进行早产检测，以安抚和监测早产症状并避免过早死亡。例如，发表在美国家庭医生杂誌上的一篇论文证实，到 2020 年，大约 3% 的怀孕将并发早产 PROM，其中三分之一的早产被确定为原因。它会导致一些围产期和新生儿问题，包括增加早产风险和 1-2% 的胎儿死亡机率。

越来越多的公司专注于开发预测早产的测试和设备，这也促进了诊断超声领域的增长，这反过来又推动了市场增长。例如，2022年3月，Ultrasound AI Inc.将利用超声技术和人工智能预测早产，实现更早干预。此外，2021 年 5 月，DC Medical 将在谢菲尔德大学研究电阻抗谱 (EIS)，以开发一种便携式早产诊断设备 EveryBaby，它认为这可能会提高预测早产的准确性。 2020 年 8 月，以色列初创公司 PulseNmore 推出了一款手持式远程超声设备，孕妇可以在家中进行超声检查，并接收医生和超音波医师的反馈。

因此，由于与早产相关的发病率和风险不断增加以及技术进步，预计在预测期内诊断超声领域的需求将会增加。

预计北美将占据较大的市场份额

由于早产的增加导致产前检测需求增加、技术创新的进步和医疗设施的增强等因素，预计北美将占据很大的市场份额。

此外，在该地区，不仅公司而且非营利组织都在专注于开髮用于评估和检测早产的测试和设备，为市场的增长做出贡献。例如，2021 年 1 月，Sera Prognostics, Inc. 与 HealthCore, Inc. 和 Anthem, Inc. 合作启动了 PRIME 试验，评估临床干预和 PreTRM 测试对改善新生儿结局的效果。此外，2021 年 5 月，Thera Prognostics 宣布与 Anthem 建立新的战略商业合作伙伴关係，作为多年协议的一部分，向怀孕会员提供 PreTRM 测试。该合作伙伴关係将为美国更多的医生和患者带来早期和准确的早产预测，使他们能够在怀孕期间做出更明智的决定。同样，2021 年 10 月，伦敦帝国理工学院 March of Dimes 早产儿研究中心的研究人员将开发出世界上第一个有助于推进早产诊断和治疗的测试。

此外，美国酒精和非法药物消费的增加也导致早产发生率增加。根据美国疾病控制和预防中心发布的数据，2022 年，14% 的孕妇报告当前饮酒，5% 报告暴饮暴食。

因此，预计在预测期内，早产率的上升以及专注于开发测试套件和设备的公司和组织将推动该地区的市场增长。

竞争格局

市场竞争激烈，有大量全球和本地参与者。主要参与者正在采取各种增长战略，例如新产品开发、产品差异化战略和扩张，以保持其市场地位。公司包括 Hologic, Inc.、Abbott、Sera Prognostics Inc.、CooperSurgical Inc. 和 IQ Products。

其他特典

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第 1 章介绍

  • 研究假设和市场定义
  • 调查范围

第 2 章研究方法论

第 3 章执行摘要

第 4 章市场动态

  • 市场概览
  • 市场促进因素
    • 早产和低出生体重的发生率增加
    • 提高了对床旁检测和 PROM 检测的认识并取得了技术进步
  • 市场抑制因素
    • 欠发达国家缺乏意识和经济限制
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按测试类型
    • 盆腔检查
    • 超音波检查
    • 生化标记
    • 子宫监测
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第 6 章竞争格局

  • 公司简介
    • Hologic, Inc
    • Abbott
    • Sera Prognostics Inc.
    • CooperSurgical Inc.
    • IQ Products
    • Qiagen N.V.
    • Biosynex
    • LifeCell International Pvt. Ltd.
    • Clinical Innovations, Inc.
    • NX Prenatal, Inc.

第 7 章市场机会与未来趋势

简介目录
Product Code: 90789

The Preterm Birth and PROM testing market is projected to grow with a CAGR of 3.35% during the forecast period (2022 - 2027).

The COVID-19 pandemic has significantly impacted the preterm birth and PROM testing market. According to a study published in the International Journal of Gynecology and Obstetrics, in October 2020, titled "The effect of the COVID-19 pandemic on maternal health due to delay in seeking health care: Experience from a tertiary center," inadequate prenatal visits were observed in one-third of the women. Lockdown and fear of infection were the leading causes of delayed health-seeking, with 44.7% of pregnancies ending in complications. Also, according to a report published in the Gynecologic and Obstetric Investigation in July 2020, infection with COVID-19 during pregnancy raises the risk of pregnancy complications such as preterm birth, preterm premature rupture of the membranes, and, in rare circumstances, maternal mortality. As a result, preterm and PROM testing have been increased to detect and prevent prenatal births and reduce complications. Thus, the market is predicted to rise due to the increased need for care.

The factors propelling the growth of the market are the rising number of preterm and low-weight births worldwide, growing advancements in point-of-care diagnostics and technological advancements in PROM testing tools, and increasing awareness regarding preterm birth and PROM testing availability.

The incidences of premature birth and increasing death among children due to preterm birth are the key driving factors for the growth of the market over the forecast period. According to the data published by the Centers for Disease Control, in 2021, the rate of preterm delivery among African-American women was 14.9%, which is 50% higher than the rate among whites (9.1%) and Hispanic women (9.8%). Similarly, according to the statistics published by the March of Dimes, in 2021, it has been observed that the preterm birth rates rose from 14.25% to 14.36% among Black women and from 11.55% to 11.61% among American Indian/Alaska Native mothers. Additionally, an article published by the Centers for Disease Control and Prevention in 2021, titled 'Preterm Birth,' reported that in 2020, in the United States, one in every ten infants born were premature.

Furthermore, the increasing number of people visiting diagnostic labs and healthcare units for testing, particularly in emerging regions, is fueling market expansion over the forecast period. Diagnostic centers are becoming more popular and widely used due to their increased reliability, cost-effectiveness, speed of results, and delivering precise diagnosis results at a low cost.

However, the lack of availability of PROM testing services and economic constraints in under-der developed countries are likely to hinder the growth of the market.

Key Market Trends

Ultrasound Segment Expects to Register a High CAGR in the Forecast Period

The ultrasound segment is witnessing significant growth in the forecast period owing to the factors such as increased incidences of preterm birth, increasing company research and development activities, and technological advancements to detect and predict preterm births.

Ultrasound can be used to check cervical tissue, as it generates images of the uterus and the baby, which can be used to identify if the cervix has dilated or effaced, as well as to improve diagnosis and forecast premature births.

With increased incidences of preterm births and associated consequences, pregnant women are more likely to engage in preterm testing during pregnancy for reassurance and monitoring of preterm birth symptoms and to avoid preterm deaths. For instance, according to an article published by the American Family Physician, in 2020, it has been observed that about 3% of pregnancies are complicated by preterm PROM, and one-third of preterm deliveries are caused by it. It raises the risk of preterm and causes several other perinatal and neonatal issues, including a 1% to 2% chance of fetal death.

The increasing company focus on developing tests and devices to predict preterm birth is also contributing to the growth of the ultrasound segment, thereby increasing the market growth. For instance, in March 2022, Ultrasound AI Inc. will use ultrasound technology and artificial intelligence to anticipate preterm birth and allow for earlier interventions. In addition, in May 2021, DC Medical developed a portable preterm diagnostic device, EveryBaby, after researching Electrical Impedance Spectroscopy (EIS) at the University of Sheffield, which could potentially improve the prediction of preterm birth. In August 2020, PulseNmore, an Israeli startup, launched a handheld tele-ultrasound device that allows pregnant women to conduct ultrasound exams at home and receive feedback from a physician or sonographer.

Thus, with the increased incidence and risk associated with preterm births and the technological advancements, the demand for the ultrasound segment is likely to increase in the forecast period.

North America is Expected to Have the Significant Market Share

North America is anticipated to have a significant share in the market owing to the factors such as increased demand for pre-birth testing due to the increased incidence of preterm births, rising technical breakthroughs, and well-established healthcare facilities in the region.

In addition, the company, as well as non-profit organizations, are focusing on developing tests and devices for evaluating and detecting preterm births in the region and contributing to the market's growth. For instance, In January 2021, Sera Prognostics, Inc. partnered with HealthCore, Inc. and Anthem, Inc. to launch the PRIME study to evaluate the effectiveness of the PreTRM test with clinical interventions to improve neonatal outcomes. In addition, In May 2021, Sera Prognostics announced a novel strategic commercial partnership with Anthem to make PreTRM Tests available to pregnant members as part of a multi-year contract. Through this partnership, many physicians and patients in the United States will have access to early and accurate preterm birth predictions, allowing them to make more informed decisions during pregnancy. Similarly, in October 2021, the researchers at the March of Dimes Prematurity Research Center at Imperial College London developed a first-of-its-kind testing device that may help advance the diagnosis and treatment of preterm birth.

Moreover, increased intake of alcohol and illicit drugs is also contributing to a rise in the incidence of preterm births in the United States. According to the data published by the Centers for Disease Control, in 2022, 14% of pregnant females reported current drinking, and 5% reported binge drinking.

Thus, increasing rates of preterm births and companies and organizations focusing on developing testing kits and devices are likely to increase the market growth in the region over the forecast period.

Competitive Landscape

The market is highly competitive with many global and local players. The major companies are adopting different growth strategies such as new product development, product differentiation strategies, and expansion to withhold the market position. Some players are Hologic, Inc., Abbott, Sera Prognostics Inc., CooperSurgical Inc., and IQ Products.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Preterm and Low-weight Births
    • 4.2.2 Increasing Awareness and Technological Advancements in Point-Of Care and PROM Testing
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness and Economic Constraints in Under-developed Countries
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Test Type
    • 5.1.1 Pelvic exam
    • 5.1.2 Ultrasound
    • 5.1.3 Biochemical Markers
    • 5.1.4 Uterine Monitoring
    • 5.1.5 Others
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Hologic, Inc
    • 6.1.2 Abbott
    • 6.1.3 Sera Prognostics Inc.
    • 6.1.4 CooperSurgical Inc.
    • 6.1.5 IQ Products
    • 6.1.6 Qiagen N.V.
    • 6.1.7 Biosynex
    • 6.1.8 LifeCell International Pvt. Ltd.
    • 6.1.9 Clinical Innovations, Inc.
    • 6.1.10 NX Prenatal, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS